Cargando…

Cell Therapy Using Induced Pluripotent Stem (iPS) Cells Meets Next-Next Generation DNA Sequencing Technology

The recent development of induced pluripotent stem (iPS) cell technology brings cell and gene therapies to patients one large step closer to reality. Technical improvements in various research fields sometimes come together fortuitously, leading to approaches to treating disease. If iPS cell technol...

Descripción completa

Detalles Bibliográficos
Autor principal:	Nakayama, Manabu
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729994/ https://www.ncbi.nlm.nih.gov/pubmed/20119527 http://dx.doi.org/10.2174/138920209788921001

Ejemplares similares

Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
por: Dey, Dilip, et al.
Publicado: (2011)

The novel application of cordycepin in maintaining stem cell pluripotency and increasing iPS cell generation efficiency
por: Wang, Chie-Hong, et al.
Publicado: (2020)

Induced pluripotent stem (iPS) cells: an up-to-the-minute review
por: Lau, Frank, et al.
Publicado: (2009)

Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review
por: Malhotra, Neeraj
Publicado: (2016)

Training the next generation of pluripotent stem cell researchers
por: Schwartz, Philip Hitchins
Publicado: (2008)

Modulation of Pluripotency in the Porcine Embryo and iPS Cells
por: Rodríguez, Aida, et al.
Publicado: (2012)

DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells
por: Liu, Kai, et al.
Publicado: (2017)

Generation of Human Induced Pluripotent Stem (iPS) Cells in Serum- and Feeder-Free Defined Culture and TGF-β1 Regulation of Pluripotency
por: Yamasaki, Sachiko, et al.
Publicado: (2014)

Efficient Generation of iPS Cells from Skeletal Muscle Stem Cells
por: Tan, Kah Yong, et al.
Publicado: (2011)

Induced pluripotent stem cells (iPS) derived disease models: In vivo to in vitro gaps
Publicado: (2018)

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells
por: Sułkowski, Maciej, et al.
Publicado: (2021)

Next generation sequencing technologies for next generation plant breeding
por: Ray, Soham, et al.
Publicado: (2014)

Correction: Generation of Human Induced Pluripotent Stem (iPS) Cells in Serum- and Feeder-Free Defined Culture and TGF-β1 Regulation of Pluripotency
Publicado: (2014)

Memorandum: next meeting of the PS committee
por: Astbury, A
Publicado: (1978)

Next generation DNA led technologies
por: Avadhanam, Sharada, et al.
Publicado: (2016)

iPS cells generation: an overview of techniques and methods
por: Telpalo-Carpio, SA, et al.
Publicado: (2013)

Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences
por: Nakamura, Y
Publicado: (2010)

An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells
por: Di Stefano, Bruno, et al.
Publicado: (2010)

Perspective: Why and How Ubiquitously Distributed, Vascular-Associated, Pluripotent Stem Cells in the Adult Body (vaPS Cells) Are the Next Generation of Medicine
por: Alt, Eckhard U., et al.
Publicado: (2021)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

Tumor-free iPS stem cells for heart cells
por: Phillips, M Ian
Publicado: (2014)

A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM)
por: House, Alisha, et al.
Publicado: (2019)

n-Butylidenephthalide (BP) Maintains Stem Cell Pluripotency by Activating Jak2/Stat3 Pathway and Increases the Efficiency of iPS Cells Generation
por: Liu, Shih-Ping, et al.
Publicado: (2012)

Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells
por: Tanaka, Naomichi, et al.
Publicado: (2020)

Combining induced pluripotent stem cell with next generation sequencing technology to gain new insights into pathobiology and treatment of pulmonary arterial hypertension
por: Rabinovitch, Marlene
Publicado: (2013)

Small RNA-mediated regulation of iPS cell generation
por: Li, Zhonghan, et al.
Publicado: (2011)

Maxadilan Prevents Apoptosis in iPS Cells and Shows No Effects on the Pluripotent State or Karyotype
por: Zhao, Zhiyi, et al.
Publicado: (2012)

The evolution of next-generation sequencing technologies
por: Akintunde, Olaitan, et al.
Publicado: (2023)

Next meeting :CLIC / PS: Next meeting : friday 3 december 1993 9.00 hrs in the large PS conference room
por: Madsen, J H B
Publicado: (1993)

Statistics for Next Generation Sequencing – Meeting Report
por: Wu, Hao, et al.
Publicado: (2012)

Human amniotic epithelial cell feeder layers maintain iPS cell pluripotency by inhibiting endogenous DNA methyltransferase 1
por: CHEN, QING, et al.
Publicado: (2013)

iPS cell technologies: significance and applications to CNS regeneration and disease
por: Okano, Hideyuki, et al.
Publicado: (2014)

Memorandum: next joint meeting of PS and SC Committees
por: Fidecaro, Maria
Publicado: (1978)

Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009)

iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016)

Notch inhibition allows oncogene independent generation of iPS cells
por: Ichida, Justin K., et al.
Publicado: (2014)

Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue
por: Ishikawa, Tetsuya
Publicado: (2017)

The next generation of accelerator technology?
Publicado: (2010)

Application of next-generation sequencing technologies in virology
por: Radford, Alan D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vrm7r0ftmg3mdt78vntqn3jn7f